Retiree
Golden Years, Golden Health
Golden Years, Golden Health
Golden Years, Golden Health
As you enter your golden years, your healthcare needs may evolve. We offer a personalized approach focused on preventive care, chronic disease management, and wellness programs to keep you living life to the fullest.
As you enter your golden years, your healthcare needs may evolve. We offer a personalized approach focused on preventive care, chronic disease management, and wellness programs to keep you living life to the fullest.
As you enter your golden years, your healthcare needs may evolve. We offer a personalized approach focused on preventive care, chronic disease management, and wellness programs to keep you living life to the fullest.
They Care About Your Health
Each team member contributes a unique set of skills and passion, united by a shared commitment to delivering exceptional healthcare experiences.
Drug-Resistant Acne
Next-gen acne treatment for the antibiotic era
VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile
Malignant Fungating Wounds
Bringing dignity back to late-stage cancer care
Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential
Uveitis
A safer path for vision preservation
VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication
Drug-Resistant Acne
Next-gen acne treatment for the antibiotic era
VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile
Malignant Fungating Wounds
Bringing dignity back to late-stage cancer care
Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential
Uveitis
A safer path for vision preservation
VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication
Drug-Resistant Acne
Next-gen acne treatment for the antibiotic era
VB1953 treats resistant P. acnes strains while calming inflammation. Offering hope for millions failed by existing topicals. - Dual action: DNA gyrase + TLR-MD2 inhibition - Proven efficacy in clindamycin non-responders - Best-in-class safety profile
Malignant Fungating Wounds
Bringing dignity back to late-stage cancer care
Vyome’s VB1953A is the first targeted therapy for MFW. Reducing odor, pain, and inflammation through a dual mechanism. - 75% odor reduction in early trials - No approved drugs exist today - Orphan designation potential
Uveitis
A safer path for vision preservation
VT1908, our non-steroidal eye drop, matches steroid performance in preclinical models—without the risks. - Targets IMPDH to block immune cell overactivity - Designed for patients who can’t use steroids - Efficient regulatory path for rare indication
See Why Families Love Agape
417
Happy Customers
98%
Success Rate
25+
Medical Employees
They Care About Your Health
Each team member contributes a unique set of skills and passion, united by a shared commitment to delivering exceptional healthcare experiences.
Dr. S Sengupta, Ph.D
Venkat Nelabhotla
Dr. Rena Patel, Ph.D., J.D.
Krishna Gupta
Mohanjit Jolly
Rajeev Mantri
Need a Support?
Services
Appointment
Technology
Virtual Health
Frequently Asked Questions
Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.
How can I schedule an appointment at Agape?
Booking an appointment is easy! You can schedule it online through our website, call our dedicated appointment line, or use our user-friendly mobile app.
What services does Agape offer for families?
Is my health information secure?
How does Agape's Virtual Health Hub work?
What devices are compatible with virtual consultations?
Need a Support?
Services
Appointment
Technology
Virtual Health
Frequently Asked Questions
Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.
How can I schedule an appointment at Agape?
What services does Agape offer for families?
Is my health information secure?
How does Agape's Virtual Health Hub work?
What devices are compatible with virtual consultations?
Need a Support?
Services
Appointment
Technology
Virtual Health
Frequently Asked Questions
Got a question? We're ready to answer! If you don't see your question listed here, please book an appointment.
How can I schedule an appointment at Agape?
Booking an appointment is easy! You can schedule it online through our website, call our dedicated appointment line, or use our user-friendly mobile app.
What services does Agape offer for families?
Is my health information secure?
How does Agape's Virtual Health Hub work?
What devices are compatible with virtual consultations?
A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.
Vyome Holdings, Inc.
Nasdaq: HIND
PRINCIPAL OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
PHONE
+1 973-832-8147
SUBSIDIARIES
Vyome Therapeutics, Inc.
OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.
OFFICE
Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.
PHONE
+91-99682-17333
*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.
Vyome Holdings, Inc.
Nasdaq: HIND
PRINCIPAL OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
PHONE
+1 973-832-8147
SUBSIDIARIES
Vyome Therapeutics, Inc.
OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.
OFFICE
Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.
PHONE
+91-99682-17333
*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.
A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.
Vyome Holdings, Inc.
Nasdaq: HIND
PRINCIPAL OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
PHONE
+1 973-832-8147
SUBSIDIARIES
Vyome Therapeutics, Inc.
OFFICE
Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138
Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.
OFFICE
Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.
PHONE
+91-99682-17333
*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.